United Therapeutics Corporation
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5.8% | 6.9% | 3.9% | 4.3% | 4.4% | 11.4% | 13.7% | 13.9% | 12.6% | 8.4% | 8.0% | 7.1% | 8.2% | 9.3% | 6.6% | 7.2% | 6.3% | 9.0% | 6.1% | 8.3% | 6.2% | 8.3% | 5.6% | 6.4% | 7.2% | 11.4% | 10.3% | 10.7% | 11.5% | 11.6% | 10.8% | 10.9% | 11.1% | 10.3% | 11.6% | 11.0% | 12.6% | 13.1% | 17.1% | 12.7% | 13.9% | |
| 94.2% | 93.1% | 96.1% | 95.7% | 95.6% | 88.6% | 86.3% | 86.1% | 87.4% | 91.6% | 92.0% | 92.9% | 91.8% | 90.7% | 93.4% | 92.8% | 93.7% | 91.0% | 93.9% | 91.7% | 93.8% | 91.7% | 94.4% | 93.6% | 92.8% | 88.6% | 89.7% | 89.3% | 88.5% | 88.4% | 89.2% | 89.1% | 88.9% | 89.7% | 88.4% | 89.0% | 87.4% | 86.9% | 82.9% | 87.3% | 86.1% | |
| 11.2% | 16.4% | 9.8% | 13.5% | 12.3% | 24.4% | 9.2% | 18.5% | 24.5% | 36.4% | 247.5% | 23.0% | 21.3% | 36.5% | 20.5% | 24.8% | 18.1% | 32.8% | 80.1% | 16.6% | 17.8% | 20.0% | 14.9% | 20.1% | 12.8% | 19.1% | 16.4% | 14.9% | 13.9% | 24.6% | 15.4% | 19.5% | 13.8% | 18.2% | 18.8% | 16.8% | 15.9% | 17.7% | 17.7% | 18.7% | 17.5% | |
| 19.6% | 26.9% | 11.1% | 11.7% | 7.0% | 30.4% | 5.1% | 15.2% | 26.7% | 12.5% | 21.6% | 6.9% | 21.1% | 27.8% | 22.5% | 25.7% | 14.2% | 36.9% | 27.3% | 21.4% | 20.7% | 26.9% | 14.0% | 26.9% | 15.7% | 29.1% | 13.9% | 18.4% | 17.5% | 17.6% | 17.9% | 21.3% | 26.5% | 18.4% | 18.1% | 20.0% | 19.2% | 19.9% | 19.9% | 17.6% | 19.1% | |
| 35.8% | 50.5% | 25.0% | 28.6% | 22.9% | 58.7% | 7.5% | 37.2% | 51.2% | 57.2% | 272.9% | 33.6% | 46.1% | 70.3% | 46.6% | 54.0% | 35.5% | 74.0% | 111.0% | 41.9% | 42.3% | 50.8% | 32.0% | 50.4% | 31.9% | 52.9% | 33.6% | 36.7% | 34.8% | 46.1% | 36.7% | 44.4% | 43.1% | 41.1% | 40.2% | 43.4% | 38.7% | 41.7% | 41.2% | 45.1% | 41.7% | |
| 58.5% | 42.6% | 71.1% | 19.9% | 72.7% | 29.9% | 78.9% | 48.9% | 36.2% | 34.5% | -180.9% | 59.3% | 45.7% | 20.4% | 46.8% | 38.8% | 58.2% | 17.0% | -17.1% | 49.8% | 51.4% | 40.9% | 62.4% | 43.2% | 60.9% | 35.7% | 56.1% | 52.5% | 53.7% | 42.3% | 52.6% | 44.7% | 45.8% | 48.6% | 48.2% | 45.6% | 48.7% | 45.2% | 41.7% | 42.2% | 44.5% | |
| 0.1% | 0.5% | 0.2% | 0.3% | 0.7% | 0.8% | 0.7% | 0.7% | 1.0% | 1.1% | 2.8% | 3.3% | 2.9% | 3.2% | 2.3% | 1.5% | 1.3% | 1.2% | 1.2% | 1.1% | 1.0% | 1.1% | 1.0% | 1.3% | 1.8% | 2.5% | 2.7% | 2.5% | 2.6% | 2.5% | 2.0% | 1.6% | 1.3% | 1.1% | 0.8% | 0.9% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | |
| 58.6% | 41.9% | 71.1% | 9.9% | 72.0% | 30.3% | 79.4% | 49.0% | 33.9% | 24.1% | -179.4% | 67.0% | 41.6% | 22.0% | 48.2% | 37.0% | 57.6% | 29.7% | 8.6% | 48.5% | 46.0% | 33.8% | 66.8% | 32.3% | 60.6% | 36.4% | 57.6% | 56.2% | 57.7% | 48.1% | 58.8% | 49.7% | 51.9% | 53.9% | 53.3% | 51.1% | 54.8% | 56.2% | 40.7% | 47.6% | 49.9% | |
| 18.9% | 15.0% | 22.9% | 22.5% | 10.0% | 26.3% | 16.6% | 10.1% | 8.1% | 7.0% | -43.0% | 12.1% | 8.6% | 5.0% | 9.5% | 7.4% | 12.6% | 4.1% | 1.1% | 9.8% | 9.4% | 6.8% | 14.9% | 7.4% | 14.2% | 9.5% | 10.1% | 12.7% | 13.8% | 12.7% | 13.6% | 10.8% | 10.6% | 12.9% | 12.8% | 12.4% | 12.4% | 10.1% | 5.6% | 5.1% | 8.3% | |
| 39.6% | 27.0% | 48.2% | -12.6% | 62.0% | 4.1% | 62.8% | 38.9% | 25.8% | 17.1% | -136.4% | 54.9% | 33.0% | 16.9% | 38.6% | 29.6% | 45.0% | 25.7% | 7.5% | 38.7% | 36.6% | 27.0% | 51.9% | 24.8% | 46.4% | 26.9% | 47.5% | 43.5% | 43.9% | 35.3% | 45.2% | 38.9% | 41.3% | 40.9% | 40.6% | 38.8% | 42.4% | 46.1% | 35.2% | 42.5% | 41.6% | |
| 60.7% | 44.5% | 73.5% | 68.9% | 74.4% | 31.0% | 82.1% | 51.5% | 38.5% | 36.5% | -173.7% | 62.0% | 48.8% | 24.8% | 50.3% | 42.0% | 61.3% | 20.7% | 13.1% | 52.3% | 49.8% | 43.8% | 70.6% | 36.3% | 64.8% | 40.3% | 62.9% | 60.8% | 62.5% | 52.7% | 63.0% | 53.9% | 55.8% | 57.6% | 55.0% | 54.7% | 57.9% | 59.5% | 44.0% | 51.0% | 53.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.